NovoCure Limited Defined Contribution Plan, Cost
NovoCure Limited (NVCR) reported Defined Contribution Plan, Cost of $2.38 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2026-02-26
- NovoCure Limited defined contribution plan, cost for fiscal 2025 was $2.38M, a 7.84% increase from fiscal 2024.
- NovoCure Limited defined contribution plan, cost for fiscal 2024 was $2.21M, a 7.12% decline from fiscal 2023.
- NovoCure Limited defined contribution plan, cost for fiscal 2023 was $2.38M, a 14.02% increase from fiscal 2022.
- NovoCure Limited defined contribution plan, cost for fiscal 2022 was $2.08M, a 5.90% increase from fiscal 2021.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2025-12-31 | $2.38M 10-K · filed 2026-02-26 |
| 2024-12-31 | $2.21M 10-K · filed 2026-02-26 |
| 2023-12-31 | $2.38M 10-K · filed 2026-02-26 |
| 2022-12-31 | $2.08M 10-K · filed 2025-02-27 |
| 2021-12-31 | $1.97M 10-K · filed 2024-02-22 |
| 2020-12-31 | $1.59M 10-K · filed 2023-02-23 |
| 2019-12-31 | $978.00K 10-K · filed 2022-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |